C45H50ClN9O3 — CID 176983534
2-chloro-4-[3-[[[2-[4-[3-cyclopropyl-5-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]indazol-1-yl]piperidin-1-yl]pyrimidin-5-yl]-hydroxymethyl]amino]-2,2,4,4-tetramethylcyclobutyl]oxybenzonitrile (PubChem CID 176983534) has the molecular formula C45H50ClN9O3 and a molecular weight of 800.41 g/mol. Its IUPAC name is 2-chloro-4-[3-[[[2-[4-[3-cyclopropyl-5-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]indazol-1-yl]piperidin-1-yl]pyrimidin-5-yl]-hydroxymethyl]amino]-2,2,4,4-tetramethylcyclobutyl]oxybenzonitrile.
| Compound Name | 2-chloro-4-[3-[[[2-[4-[3-cyclopropyl-5-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]indazol-1-yl]piperidin-1-yl]pyrimidin-5-yl]-hydroxymethyl]amino]-2,2,4,4-tetramethylcyclobutyl]oxybenzonitrile |
|---|---|
| PubChem CID | 176983534 |
| Molecular Formula | C45H50ClN9O3 |
| Molecular Weight | 800.41 g/mol |
| Exact Mass | 799.37 |
| IUPAC Name | 2-chloro-4-[3-[[[2-[4-[3-cyclopropyl-5-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]indazol-1-yl]piperidin-1-yl]pyrimidin-5-yl]-hydroxymethyl]amino]-2,2,4,4-tetramethylcyclobutyl]oxybenzonitrile |
| SMILES | C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(C3CC3)nn4C3CCN(c4ncc(C(O)NC5C(C)(C)C(Oc6ccc(C#N)c(Cl)c6)C5(C)C)cn4)CC3)c2N1 |
| InChI | InChI=1S/C45H50ClN9O3/c1-25-19-37(56)51-35-8-6-7-32(39(35)50-25)27-12-14-36-33(20-27)38(26-9-10-26)53-55(36)30-15-17-54(18-16-30)43-48-23-29(24-49-43)40(57)52-41-44(2,3)42(45(41,4)5)58-31-13-11-28(22-47)34(46)21-31/h6-8,11-14,20-21,23-26,30,40-42,50,52,57H,9-10,15-19H2,1-5H3,(H,51,56)/t25-,40?,41?,42?/m1/s1 |
| InChIKey | MDHBNKQCDFGZBX-JKLQYLNQSA-N |
| XLogP | 8.34 |
| TPSA | 153.25 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 58 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 800.41 |
| LogP ≤ 5 | 8.34 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|